Tang Capital's Concentra Engages in Aggressive Acquisition Strategy Amid Abundant Biotech Opportunities

Tang Capital’s Concentra Engages in Aggressive Acquisition Strategy Amid Abundant Biotech Opportunities

Tang Capital's Concentra Engages in Aggressive Acquisition Strategy Amid Abundant Biotech Opportunities